Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New COX-2 inhibitors from Uriach have high potency, selectivity and oral antiinflammatory activity

Sep. 27, 2000

The hypothalamo-hypophyseal-adrenal axis influences arthritis development, treatment

Sep. 26, 2000

Shionogi presents new MMP inhibitors with cyclic structure

Sep. 22, 2000

Indoles under evaluation at AstraZeneca as potential antiinflammatory agents

Sep. 21, 2000

Celecoxib associated with fewer adverse effects than NSAIDs, according to CLASS

Sep. 18, 2000

Series of patents covers American Cyanamid's new TACE inhibitors

Sep. 15, 2000

Potent hydroxamate-based MMP-2 inhibitors disclosed by Abbott

Sep. 15, 2000

Toleragen candidate for antibody-mediated thrombosis effective in preclinical model

Sep. 15, 2000

Pyrazoles as selective CB2 receptor modulators patented by SmithKline Beecham

Sep. 13, 2000

Lupus therapy candidate granted orphan drug designation

Sep. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...